# MYOC

## Overview
The MYOC gene encodes the protein myocilin, which is primarily known for its role in the eye, particularly in the pathology of glaucoma. Myocilin is a secreted glycoprotein that is characterized by its complex structure, including a coiled-coil domain and an olfactomedin-like (OLF) domain, the latter being a common site for pathogenic mutations (Katoli2018Fulllength; Zhou2022Structure‒function‒pathogenicity). Functionally, myocilin is involved in various cellular processes, including the differentiation of mesenchymal stem cells into osteoblasts and the regulation of cell proliferation and survival through pathways such as MAPK and ERK (Joe2014Myocilin; Kwon2013Myocilin). Mutations in MYOC are associated with primary open-angle glaucoma (POAG) and juvenile open-angle glaucoma (JOAG), where they lead to protein misfolding and accumulation, contributing to increased intraocular pressure and optic nerve damage (Zhou2022Structure‒function‒pathogenicity; Hewitt2007Myocilin). Understanding the structure and function of myocilin, as well as its interactions with other proteins, is crucial for elucidating its role in glaucoma and developing potential therapeutic strategies.

## Structure
The MYOC (myocilin) protein is characterized by a complex molecular structure that includes several distinct domains. It contains a secretion signal, an N-glycosylation site, a coiled-coil region with a leucine zipper, and a C-terminal five-bladed beta-propeller known as the olfactomedin-like (OLF) domain (Katoli2018Fulllength). The OLF domain is particularly significant as it is the site where most pathologic mutations occur, contributing to diseases such as glaucoma (Zhou2022Structure‒function‒pathogenicity).

The protein predominantly exists as a dimer, although it can form higher-order oligomers under certain conditions (Katoli2018Fulllength). The coiled-coil domain of MYOC includes parallel tetramer and dimer subdomains, with the leucine zipper region forming a parallel dimer with a left-handed supercoiled twist (Hill2017Structure). 

Post-translational modifications of MYOC include glycosylation and disulfide bond formation, which are crucial for its stability and function (Zhou2022Structure‒function‒pathogenicity). The protein's structure is further complicated by its tendency to misfold, particularly in the presence of mutations, leading to secretion defects and intracellular accumulation (Zhou2022Structure‒function‒pathogenicity). These structural features are essential for understanding the role of MYOC in glaucoma pathology.

## Function
The MYOC gene encodes the protein myocilin, which plays a significant role in various cellular processes in healthy human cells. Myocilin is involved in the differentiation of mesenchymal stem cells (MSCs) into osteoblasts, the cells responsible for bone formation. This process is facilitated through the activation of mitogen-activated protein kinase (MAPK) signaling pathways, including p38, Erk1/2, and JNK, and involves transcription factors such as Runx2 and Dlx5 (Kwon2013Myocilin). Myocilin expression increases during MSC differentiation, and its presence enhances osteogenic differentiation, suggesting a role in bone formation and maintenance (Kwon2013Myocilin).

In addition to its role in bone biology, myocilin is implicated in cell proliferation and survival. It activates the ERK signaling pathway, which is crucial for these processes, and helps protect cells from apoptosis (Joe2014Myocilin). Myocilin also interacts with components of the Wnt signaling pathway, potentially influencing actin cytoskeleton reorganization and cell migration (Joe2014Myocilin). These functions highlight myocilin's importance in maintaining cellular health and its potential impact on tissue regeneration and repair.

## Clinical Significance
Mutations in the MYOC gene are significantly associated with primary open-angle glaucoma (POAG) and juvenile open-angle glaucoma (JOAG). These mutations account for approximately 2%-4% of adult-onset POAG cases and 8%-36% of JOAG cases (Zhou2022Structure‒function‒pathogenicity; Hewitt2007Myocilin). The majority of pathogenic mutations are located in the olfactomedin (OLF) domain of the protein, leading to misfolded proteins that accumulate in the trabecular meshwork cells, contributing to increased intraocular pressure (IOP) and optic nerve damage (Zhou2022Structure‒function‒pathogenicity; Liuska2021Prevalence).

MYOC mutations are typically inherited in an autosomal dominant manner and are characterized by gain-of-function effects, where the abnormal proteins disrupt cellular processes, leading to glaucoma (Kim2001Targeted; Gould2004Genetically). Specific mutations, such as p.K423E and p.C25R, have been identified in familial cases, indicating their pathogenic nature (Bruttini2003Mutations). The MYOC Y437H mutation has been linked to increased levels of TGF-β2, further implicating it in the pathogenesis of POAG (Yang2020Crosstalk).

The prevalence of MYOC mutations varies among populations, with certain variants being more common in East and South Asian populations (Liuska2021Prevalence). Genetic screening for MYOC mutations is suggested to aid in early diagnosis and management of glaucoma, particularly in high-risk groups (Ennis2009Prevalence).

## Interactions
Myocilin (MYOC) is known to interact with several proteins, playing a significant role in the pathology of glaucoma. One notable interaction is with the αB-crystallin (CRYAB) chaperone. This interaction is particularly significant in the context of glaucoma-associated MYOC mutations, such as the Y435H variant. The binding of MYOC to CRYAB impedes protein clearance in trabecular meshwork cells, leading to the accumulation of protein aggregates that can compromise cell function and viability. This interaction affects the ubiquitin-proteasome pathway and prevents CRYAB from performing its essential cellular functions, such as acting as a chaperone and inhibiting apoptosis (Lynch2018Binding).

MYOC also interacts with extracellular matrix (ECM) proteins, including fibronectin, elastin, and collagen type IV. Mutant MYOC, particularly the Y437H variant, leads to increased intracellular accumulation of these ECM proteins in the endoplasmic reticulum of trabecular meshwork cells. This accumulation is associated with endoplasmic reticulum stress and altered ECM dynamics, contributing to the pathology of glaucoma (Kasetti2016Expression).

These interactions highlight the role of MYOC in cellular stress responses and protein clearance mechanisms, which are crucial in understanding its involvement in glaucoma pathology.


## References


[1. (Kim2001Targeted) Byong Su Kim, Olga V. Savinova, Mark V. Reedy, Janice Martin, Yi Lun, Lin Gan, Richard S. Smith, Stanislav I. Tomarev, Simon W. M. John, and Randy L. Johnson. Targeted disruption of the myocilin gene (myoc) suggests that human glaucoma-causing mutations are gain of function. Molecular and Cellular Biology, 21(22):7707–7713, November 2001. URL: http://dx.doi.org/10.1128/MCB.21.22.7707-7713.2001, doi:10.1128/mcb.21.22.7707-7713.2001. This article has 309 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.21.22.7707-7713.2001)

[2. (Zhou2022Structure‒function‒pathogenicity) Biting Zhou, Xiaojia Lin, Zhong Li, Yihua Yao, Juhua Yang, and Yihua Zhu. Structure‒function‒pathogenicity analysis of c-terminal myocilin missense variants based on experiments and 3d models. Frontiers in Genetics, October 2022. URL: http://dx.doi.org/10.3389/fgene.2022.1019208, doi:10.3389/fgene.2022.1019208. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.1019208)

[3. (Liuska2021Prevalence) Perttu J. Liuska, Mika Harju, Tero T. Kivelä, and Joni A. Turunen. Prevalence of myoc risk variants for glaucoma in different populations. Acta Ophthalmologica, January 2021. URL: http://dx.doi.org/10.1111/aos.14738, doi:10.1111/aos.14738. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/aos.14738)

[4. (Hewitt2007Myocilin) Alex W. Hewitt. Myocilin gly252arg mutation and glaucoma of intermediate severity in caucasian individuals. Archives of Ophthalmology, 125(1):98, January 2007. URL: http://dx.doi.org/10.1001/ARCHOPHT.125.1.98, doi:10.1001/archopht.125.1.98. This article has 21 citations.](https://doi.org/10.1001/ARCHOPHT.125.1.98)

[5. (Bruttini2003Mutations) Mirella Bruttini. Mutations in the myocilin gene in families with primary open-angle glaucoma and juvenile open-angle glaucoma. Archives of Ophthalmology, 121(7):1034, July 2003. URL: http://dx.doi.org/10.1001/ARCHOPHT.121.7.1034, doi:10.1001/archopht.121.7.1034. This article has 80 citations.](https://doi.org/10.1001/ARCHOPHT.121.7.1034)

[6. (Kasetti2016Expression) Ramesh B. Kasetti, Tien N. Phan, J. Cameron Millar, and Gulab S. Zode. Expression of mutant myocilin induces abnormal intracellular accumulation of selected extracellular matrix proteins in the trabecular meshwork. Investigative Opthalmology &amp; Visual Science, 57(14):6058, November 2016. URL: http://dx.doi.org/10.1167/iovs.16-19610, doi:10.1167/iovs.16-19610. This article has 46 citations.](https://doi.org/10.1167/iovs.16-19610)

[7. (Ennis2009Prevalence) S Ennis, J Gibson, H Griffiths, D Bunyan, A J Cree, D Robinson, J Self, A MacLeod, and A Lotery. Prevalence of myocilin gene mutations in a novel uk cohort of poag patients. Eye, 24(2):328–333, May 2009. URL: http://dx.doi.org/10.1038/eye.2009.73, doi:10.1038/eye.2009.73. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/eye.2009.73)

8. (Hill2017Structure) Structure and misfolding of the flexible tripartite coiled coil domain of glaucoma-associated myocilin. This article has 1 citations.

[9. (Lynch2018Binding) Jeffrey M. Lynch, Bing Li, Parvaneh Katoli, Chuanxi Xiang, Barrett Leehy, Nalini Rangaswamy, Veronica Saenz-Vash, Y. Karen Wang, Hong Lei, Thomas B. Nicholson, Erik Meredith, Dennis S. Rice, Ganesh Prasanna, and Amy Chen. Binding of a glaucoma-associated myocilin variant to the αb-crystallin chaperone impedes protein clearance in trabecular meshwork cells. Journal of Biological Chemistry, 293(52):20137–20156, December 2018. URL: http://dx.doi.org/10.1074/jbc.ra118.004325, doi:10.1074/jbc.ra118.004325. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.004325)

[10. (Yang2020Crosstalk) Yang Yang, AL Sabri Waled Abdulghani Abdulatef, LuSi Zhang, Haibo Jiang, Zhou Zeng, Haibo Li, and Xiaobo Xia. Cross-talk between myoc p. y437h mutation and tgf-β2 in the pathology of glaucoma. International Journal of Medical Sciences, 17(8):1062–1070, 2020. URL: http://dx.doi.org/10.7150/ijms.43614, doi:10.7150/ijms.43614. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijms.43614)

[11. (Joe2014Myocilin) Myung Kuk Joe, Heung Sun Kwon, Radu Cojocaru, and Stanislav I. Tomarev. Myocilin regulates cell proliferation and survival. Journal of Biological Chemistry, 289(14):10155–10167, April 2014. URL: http://dx.doi.org/10.1074/jbc.M113.547091, doi:10.1074/jbc.m113.547091. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M113.547091)

[12. (Katoli2018Fulllength) Parvaneh Katoli, Adarsh Godbole, Michael J. Romanowski, Kirk Clark, Erik Meredith, Veronica Saenz-Vash, Y. Karen Wang, Nancy Lewicki, Andrew A. Nguyen, and Jeffrey M. Lynch. Full-length myocilin protein is purified from mammalian cells as a dimer. Protein Expression and Purification, 147:38–48, July 2018. URL: http://dx.doi.org/10.1016/j.pep.2018.02.008, doi:10.1016/j.pep.2018.02.008. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pep.2018.02.008)

[13. (Gould2004Genetically) Douglas B. Gould, Laura Miceli-Libby, Olga V. Savinova, Mario Torrado, Stanislav I. Tomarev, Richard S. Smith, and Simon W. M. John. Genetically increasing myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Molecular and Cellular Biology, 24(20):9019–9025, October 2004. URL: http://dx.doi.org/10.1128/mcb.24.20.9019-9025.2004, doi:10.1128/mcb.24.20.9019-9025.2004. This article has 90 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.24.20.9019-9025.2004)

[14. (Kwon2013Myocilin) Heung Sun Kwon, Thomas V. Johnson, and Stanislav I. Tomarev. Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling. Journal of Biological Chemistry, 288(23):16882–16894, June 2013. URL: http://dx.doi.org/10.1074/jbc.m112.422972, doi:10.1074/jbc.m112.422972. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.422972)